Plasmodium falciparum heat shock proteins as antimalarial drug targets : An update

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved..

Global efforts to eradicate malaria are threatened by multiple factors, particularly the emergence of antimalarial drug resistant strains of Plasmodium falciparum. Heat shock proteins (HSPs), particularly P. falciparum HSPs (PfHSPs), represent promising drug targets due to their essential roles in parasite survival and virulence across the various life cycle stages. Despite structural similarities between human and malarial HSPs posing challenges, there is substantial evidence for subtle differences that could be exploited for selective drug targeting. This review provides an update on the potential of targeting various PfHSP families (particularly PfHSP40, PfHSP70, and PfHSP90) and their interactions within PfHSP complexes as a strategy to develop new antimalarial drugs. In addition, the need for a deeper understanding of the role of HSP complexes at the host-parasite interface is highlighted, especially heterologous partnerships between human and malarial HSPs, as this opens novel opportunities for targeting protein-protein interactions crucial for malaria parasite survival and pathogenesis.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Cell stress & chaperones - 29(2024), 2 vom: 20. Apr., Seite 326-337

Sprache:

Englisch

Beteiligte Personen:

Ahmad, Tanveer [VerfasserIn]
Alhammadi, Bushra A [VerfasserIn]
Almaazmi, Shaikha Y [VerfasserIn]
Arafa, Sahar [VerfasserIn]
Blatch, Gregory L [VerfasserIn]
Dutta, Tanima [VerfasserIn]
Gestwicki, Jason E [VerfasserIn]
Keyzers, Robert A [VerfasserIn]
Shonhai, Addmore [VerfasserIn]
Singh, Harpreet [VerfasserIn]

Links:

Volltext

Themen:

Antimalarial drugs
Antimalarials
HSP70 Heat-Shock Proteins
Heat shock proteins
Heat-Shock Proteins
Journal Article
Malaria
Molecular chaperones
Plasmodium falciparum
Protein folding
Protozoan Proteins
Review

Anmerkungen:

Date Completed 16.04.2024

Date Revised 16.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.cstres.2024.03.007

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370084276